National Institute of Neurological Disorders and Stroke (NINDS)
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, National Institute of Neurological Disorders and Stroke (NINDS) sits in the top decile of US sponsors by registered trial count (#61 of 15,742 sponsors by registered trial count).
National Institute of Neurological Disorders and Stroke (NINDS): 567 sponsored US clinical trials, 48 recruiting.
National Institute of Neurological Disorders and Stroke (NINDS) sponsors 567 registered US clinical trials on ClinicalTrials.gov, 48 of them currently recruiting, and 467 completed. 16 of these trials are in Phase 3-4 (later-stage) and 158 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 23 trials.
Top-decile sponsor footprint
National Institute of Neurological Disorders and Stroke (NINDS) ranks in the top decile of sponsors by registered trial count (#61 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
467 of 508 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
567 total, page 4 of 12
Genetics of Motor Learning
NCT01105845
The Influence of Sensory Stimuli on Gait Imagery in Patients With Freezing of Gait
NCT01071590
Screening Protocol for Patients With Stroke
NCT01021033
Physiological Investigations of Movement Disorders
NCT01019343
Cerebral Activity Related to Primary Motor Stereotypies in Children: An EEG Study.
NCT01037361
Recording and Modulation of Neuronal Mechanisms During Operant Conditioning: a MEG Study
NCT01006109
50 Hz Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Parkinson's Disease
NCT00977184
High-Density Direct Current Brain Polarization
NCT00944931
A Study of Acetyl Hexapeptide-8 (AH8) in Treatment of Blepharospasm
NCT00942851
GABA/Glutamate Balance in Temporal Lobe Epilepsy With and Without Major Depression
NCT00931619
Biomarkers of Risk of Parkinson Disease
NCT00775853
Changes in the Posterior Parietal Cortex - Primary Motor Cortex Pathway Induced by Motor Training
NCT00904332
Investigation of Neurofeedback With Real-Time fMRI in Healthy Volunteers and Patients With Hyperkinetic Movement Disorders
NCT00885040
Effect of Reward on Learning in Motor Cortex
NCT00885131
Magnetoencephalography in Absence Seizures
NCT00884351
An Open Label Dose Escalation Safety Study of Convection-Enhanced Delivery of IL13-PE38QQR in Patients With Progressive Pediatric Diffuse Infiltrating Brainstem Glioma and Supratentorial High-grade Glioma
NCT00880061
Exploring a Motor Learning Technique Based on the Mirror Motor Neuron System
NCT00872183
Double-Blind, Placebo Controlled Pilot Study of Octanoic Acid in Essential Tremor
NCT00848172
Using Transcranial Direct Current Stimulation (tDCS) to Enhance the Benefit of Movement Training in Stoke Patients
NCT00783913
Role of the Sensory Experience in Generating Motor Tics in Tourette Syndrome
NCT00755339
Warfighter Head Injury Study
NCT00754169
Brain Activity During Strategic Planning
NCT00728741
Brain Activity in Time Discrimination and Sensory Input
NCT00726050
Role of Neurotransmission and Functional CNS Networks in Spasmodic Dysphonia
NCT00713414
Language Mapping in Patients With Epilepsy
NCT00706160
Autoimmunity in Neurologic Complications of Celiac Disease
NCT00692861
Lithium Treatment for Patients With Spinocerebellar Ataxia Type I
NCT00683943
Aneurysms and Carotid Artery Block in Newborns
NCT00646672
Relationship of HHV-6B Virus to Seizures and Brain Injury
NCT00597285
Association Between Focal Dystonia and Complex Regional Pain Syndrome
NCT00595439
Motor Cortex Reward Signaling in Parkinson Disease
NCT00558766
Neurobiology of Functional Movement Disorder and Non-Epileptic Seizures
NCT00500994
Augmenting Effects of L-DOPS With Carbidopa and Entacapone
NCT00547911
Brain Changes in Blepharospasm
NCT00500799
Brain Function in Performance of Motor Tasks
NCT00498329
Brain Changes in Blepharospasm
NCT00487383
Movement of Epiglottis During Swallowing
NCT00475943
Influence of Area of Brain Damage on Brain Reorganization After Chronic Stroke
NCT00474292
Botulinum Toxin to Treat Restless Legs Syndrome
NCT00479154
Effect of Electrical Stimulation (DC Polarization) to the Brain on Memory
NCT00471107
Measuring Blood Flow in the Brain
NCT00466934
Characteristics of Parkinson s Disease Associated With the LRRK-2 Gene Mutation
NCT00467090
A Study to Evaluate and Characterize the Effect of Pharmacological Chemicals on Blood From Patients With Gaucher Disease
NCT00465062
Brain Activity in People With Functional Movement Disorders
NCT00448084
The Role of Serotonin in Seizures
NCT00439387
Brain Peripheral Benzodiazepine Receptors in Patients With Multiple Sclerosis
NCT00432900
Sequence Effect in Parkinson's Disease
NCT00431366
Spaced Versus Massed Skill Learning
NCT00426465
Modulation of Motor Function by Stimulation of the Central and Peripheral Nervous System
NCT00453505
Direct Current Brain Polarization of the Frontal Lobes
NCT00424216
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 80 |
| Phase 2 | 78 |
| Phase 3 | 11 |
| Phase 4 | 5 |
Therapeutic Areas
What is open in the National Institute of Neurological Disorders and Stroke (NINDS) pipeline
48 recruiting of 567 indexed (8% open); 467 completed (82%).
Phase mix: 16 late (III/IV) vs 158 early (I/II) (early-phase heavy).
Top condition: Healthy (23 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
National Institute of Neurological Disorders and Stroke (NINDS): open-pipeline peers nationwide
Peers matched on 567 registered trials and 8% open enrollment, not the therapeutic-area sidebar.
National Institute of Neurological Disorders and Stroke (NINDS) sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 567 trials (± recruiting share)
- Children's Hospital Medical Center, Cincinnati · 571 trials · 19% recruiting
- University of Maryland, Baltimore · 560 trials · 18% recruiting
- Amgen · 558 trials · 10% recruiting
- Merck Sharp & Dohme · 558 trials · 22% recruiting
Sponsors near 8% open enrollment (± trial volume)
- National Jewish Health · 8% recruiting · 83 trials
- ACADIA Pharmaceuticals · 9% recruiting · 35 trials
- Texas Tech University Health Sciences Center, El Paso · 9% recruiting · 35 trials
- Boehringer Ingelheim · 8% recruiting · 515 trials
Related
What to do with this National Institute of Neurological Disorders and Stroke (NINDS) page
567 registered trials is a research-attention snapshot, not an endorsement of National Institute of Neurological Disorders and Stroke (NINDS) or any single study.
- 48 of National Institute of Neurological Disorders and Stroke (NINDS)'s trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Healthy is the condition National Institute of Neurological Disorders and Stroke (NINDS) studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
National Institute of Neurological Disorders and Stroke (NINDS) pipeline card: 567 registered trials from official public datasets.Report a data error.